A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
Clinical trial NCT04102020 · COMPLETED
Trial details
- NCT number
- NCT04102020
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-26
- Primary completion
- 2022-09-29
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.